Manulife (Manufacturers Life Insurance)
ABOS icon

Manulife (Manufacturers Life Insurance)’s Acumen Pharmaceuticals ABOS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-52,333
Closed -$130K – 2971
2024
Q3 		$130K Sell
52,333
-7,663
-13% -$20.8K ﹤0.01% 2793
2024
Q2 		$145K Sell
59,996
-45
-0.1% -$143 ﹤0.01% 2717
2024
Q1 		$243K Buy
+60,041
New +$226K ﹤0.01% 2497
2022
Q2 		– Sell
-12,200
Closed -$47.7K – 2997
2022
Q1 		$47.7K Buy
+12,200
New +$66.4K ﹤0.01% 3043

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ABOS Position: Q4 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Acumen Pharmaceuticals (ABOS) in Q4 2024, closing a stake of 52,333 shares — an estimated $130K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ABOS in Q1 2022 and held it in 4 quarters. The position peaked at $243K in Q1 2024. 80 funds tracked by Wall St. Rank hold ABOS as of Q4 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Acumen Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 52,333 Acumen Pharmaceuticals shares in Q4 2024, an estimated $130K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Acumen Pharmaceuticals in Q1 2022 and held it in 4 quarters.
  • Manulife (Manufacturers Life Insurance)'s Acumen Pharmaceuticals position peaked at $243K in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q4 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2024, filed 14 Feb 2025.